ACHL News and Press, Achilles Therapeutics plc

MacDonald Mines Exploration Ltd. (MCDMF) is expected to report for quarter end 2025-03-31 ConvaTec Group Plc ADR (CNVVY) is expected to report for Q1 2025 Freenet AG Registered Shares (FRTAF) is expected to report for quarter end 2025-03-31 Lion Copper and Gold (LCGMF) is expected to ...

Nutanix Inc. (NTNX) is expected to report $0.08 for Q3 2025 Correlate Energy Corp. (CIPI) is expected to report for quarter end 2025-03-31 HP Inc. (HPQ) is expected to report $0.8 for Q2 2025 Reservoir Media Inc.. (RSVR) is expected to report $0.04 for Q4 2025 National Bank Of Can...

National Bankshares Inc. (NKSH) is expected to report $0.52 for Q1 2025 Baidu Inc. (BIDU) is expected to report $1.34 for Q1 2025 Sagimet Biosciences Inc. (SGMT) is expected to report $-0.79 for Q1 2025 MingZhu Logistics Holdings Limited (YGMZ) is expected to report for quarter end 20...

Aeva Technologies Inc. (AEVA) is expected to report $-0.59 for Q1 2025 Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil) (LND) is expected to report for Q3 2025 Omron Corporation ADR (OMRNY) is expected to report for Q4 2025 Sezzle Inc. (SEZL) is expected to report $0.3...

2025-02-28 09:06:47 ET Read the full article on Seeking Alpha For further details see: Achilles Therapeutics announces voluntary Nasdaq delisting, SEC deregistration

LONDON, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL) (the Company) today announced that it has formally notified The Nasdaq Stock Market LLC (Nasdaq) of its intention to voluntarily delist its American Depositary Shares (ADSs) from Nasdaq and its intent to deregister...